AstraZeneca Plc, the U.K. drugmaker developing a Covid-19 vaccine with the University of Oxford, has been cleared by U.S. regulators to restart a trial halted in the country for more than a month on concerns about a volunteer who became ill. The U.S. Food and Drug Administration authorized the trial to resume Friday, according to […]
The post AstraZeneca cleared by U.S. regulators to resume COVID vaccine trial appeared first on Up News Info.
Read More